Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development

Abstract

The cannabinoid molecules are derived from Cannabis sativa plant which acts on the cannabinoid receptors types 1 and 2 (CB1 and CB2) which have been explored as potential therapeutic targets for drug discovery and development. Currently, there are numerous cannabinoid based synthetic drugs used in clinical practice like the popular ones such as nabilone, dronabinol, and Δ9-tetrahydrocannabinol mediates its action through CB1/CB2 receptors. However, these synthetic based Cannabis derived compounds are known to exert adverse psychiatric effect and have also been exploited for drug abuse. This encourages us to find out an alternative and safe drug with the least psychiatric adverse effects. In recent years, many phytocannabinoids have been isolated from plants other than Cannabis. Several studies have shown that these phytocannabinoids show affinity, potency, selectivity, and efficacy towards cannabinoid receptors and inhibit endocannabinoid metabolizing enzymes, thus reducing hyperactivity of endocannabinoid systems. Also, these naturally derived molecules possess the least adverse effects opposed to the synthetically derived cannabinoids. Therefore, the plant based cannabinoid molecules proved to be promising and emerging therapeutic alternative. The present review provides an overview of therapeutic potential of ligands and plants modulating cannabinoid receptors that may be of interest to pharmaceutical industry in search of new and safer drug discovery and development for future therapeutics.

The Essential Medicinal Chemistry of Curcumin

“…Unfortunately, articles are still published that cite the originally reported activity and selectivity of 1 for CB1, without acknowledgment of the subsequent retraction. 143 …”

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats

“…The ECS is composed of the cannabinoid receptors CB1R and CB2R and their degradation enzyme and synthetase. These two receptors are G protein-coupled receptors [13]. CB1R plays an important role in adjusting bone mass and bone remodeling.…”

Hypocholesterolemic effect of β-caryophyllene in rats fed cholesterol and fat enriched diet

“…), ( 8 ) clove ( Eugenia caryophyllata ), ( 9 ) thyme ( Salvia spp. ), ( 10 ) rosemary ( Rosmarinus officinalis ), ( 11 ) and hops ( Humulus lupulus ) and probably many other species. ( 12 ) For example, BCP was found to form up to 35% of the essential oil of the hemp plant Cannabis sativa .…”

“…BCP was approved by several food and flavor regulatory agencies for use as a food additive and was classified as a “generally regarded as safe” compound. ( 11 ) This compound created an interest to many researchers as a lead for drug development, ( 21 ) therefore, this work has been undertaken to test the hypothesis that BCP has a hypolipidemic effects in Wistar rats fed a high cholesterol and fat diet.…”